TMCnet - World's Largest Communications and Technology Community



Research and Markets: Global Oligonucleotide Synthesis (Equipment, Reagents & Synthesized Oligonucleotides) Market 2014-2019 - Product & Services, End-User, Application Analysis
[September 05, 2014]

Research and Markets: Global Oligonucleotide Synthesis (Equipment, Reagents & Synthesized Oligonucleotides) Market 2014-2019 - Product & Services, End-User, Application Analysis

DUBLIN --(Business Wire)--

Research and Markets ( has announced the addition of the "Oligonucleotide Synthesis Market by Product & Services, End-User , Application - Global Forecast to 2019" report to their offering.

The global oligonucleotide synthesis market is expected to reach $1,712.1 million by 2019 from $1,070.7 million in 2014, growing at a CAGR of 9.8% from 2014 to 2019.

Oligonucleotide synthesis has a vast number of applications in nucleic acid array-based technologies, library preparations, next-generation sequencing methods, genomics, nucleic acid-based detection, cell cultures, diagnostics, therapeutics, human identity testing, cloning and genetic engineering, and synthetic biology, among others. Apart from the growing applications of oligos, increasing R&D expenditure in pharmaceutical and biotechnology companies, the evolving significance of RNA-interference oligos in therapeutics and diagnostics, increasing venture capitalist and governmental funding and support, and rapid technological innovations are other factors driving this market's growth. The relatively-untapped Asia-Pacific market, and the growth in magnitude of R&D activities in the region, has opened an array of opportunities for players in the oligonucleotide synthesis market. However, regulatory barriers, especially for therapeutic oligos, and downward pricing pressure are the major factors restraining the growth of this market.

By products and services, the market is broadly segmented into equipment, reagents, and synthesized oligonucleotides. Among these segments, the synthesized oligonucleotides market segment is expected to register the highest growth rate during the forecast period, owing to the increasing number of applications of synthesized oligonucleotides in research, diagnostics and therapeutics, and a growing demand for custom oligos.

The market, by applications, is classified into diagnostics, research, and therapeutics. Research applications are further segmented into PCR (News - Alert), qPCR, sequencing, gene synthesis, and others. The therapeutics market is further segmented into DNA/antisense oligos, RNAi, aptamers, and others. In terms of applications, the research segment commanded the largest share in 2014, while the diagnostics segment is expected to be the fastest-growing segment in the oligonucleotide synthesis market. The therapeutics segment is gaining increasing importance with growing RNAi applications. However, stringent regulatory requirements pose a major challenge for this market.

By end users, the market is segmented into academic research institutes, pharmaceutical and biotech firms, and diagnostic labs. Academic research institutes accounted for the largest share of the market in 2014; however, diagnostic laboratories are expected to be the fastest-growing end user segment during the forecast period, owing to growth in the molecular diagnostics field.

Scope of the Report

By Products & Services

  • Equipment
  • Reagents
  • Synthesized Oligonucleotides

By Product Type

  • Primers
  • Probes
  • Intermediate-Scale Synthesis
  • Large-Scale Synthesis

By Service Type

  • Pre-designed Oligos
  • Custom Oligos

By Application



  • PCR
  • QPCR
  • Sequencing
  • Gene Synthesis
  • Others


  • DNA/Antisense Oligos
  • RNAi Oligos
  • Aptamer Oligos
  • Others

By End User

  • Academic Research Institutes
  • Diagnostic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Others

Companies Mentioned

  • Bioautomation Corporation
  • Biosearch Technologies, Inc.
  • Eurofins Genomics (A Subsidiary of Eurofins Scientific Group)
  • Eurogentec (A Subsidiary of Kaneka Corporation)
  • GE Healthcare (A Subsidiary of General Electric Company)
  • Genedesign, Inc.
  • Integrated Dna Technologies
  • Sigma-Aldrich Corporation
  • Trilink Biotechnologies, Inc.
  • Thermo Fisher Scientific, Inc.

For more information visit

[ Back To's Homepage ]

Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments:
Comments about this site:


© 2018 Technology Marketing Corporation. All rights reserved | Privacy Policy